This is the authors' abstract. We don't add key points for this paper.
Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ferner et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: